Cleared Traditional

K161513 - Anti-Borrelia burgdorferi US Westernblot (IgG)

K161513 is an FDA 510(k) clearance for Anti-Borrelia burgdorferi US Westernblo..., manufactured by Euroimmun US. The device is a Class 2 Microbiology device with product code LSR cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K161513 · Euroimmun US · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2016
Decision
84d
Days
Class 2
Risk

K161513 is an FDA 510(k) clearance for the Anti-Borrelia burgdorferi US Westernblot (IgG). Classified as Reagent, Borrelia Serological Reagent (product code LSR), Class II - Special Controls.

Submitted by Euroimmun US (Morris Plains, US). The FDA issued a Cleared decision on August 25, 2016 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3830 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Euroimmun US devices

FDA 510(k) Submission Details - K161513

510(k) Number K161513 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2016
Decision Date August 25, 2016
Days to Decision 84 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 102d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LSR Device Classification - Class 2, Special Controls

Product Code LSR Reagent, Borrelia Serological Reagent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LSR Reagent, Borrelia Serological Reagent

All 97
Devices cleared under the same product code (LSR) and FDA review panel - the closest regulatory comparables to K161513.
Borrelia B31 ViraChip IgM Test Kit
K163695 · Viramed Biotech AG · Aug 2017
Borrelia B31 ViraChip IgG Test Kit
K163504 · Viramed Biotech AG · Jul 2017
Lyme B. burgdorferi (IgG) MarStripe Test
K163095 · Trinity Biotech · Feb 2017
EUROIMMUN LYME ELISA(IgG/IgM)
K142038 · Euroimmun US · May 2015
VIDAS LYME IGM
K122979 · Biomerieux S.A. · Jun 2013
VIDAS LYME IGG
K122986 · Biomerieux S.A. · Mar 2013